Award
National Institute of Allergy and Infectious Diseases 5U01AI172987-04
Development of targeted microbiome therapeutics and dietary interventions for potent intestinal barrier promotion to minimize GI-ARS
Recipient
UNIV OF MASSACHUSETTS MED SCH WORCESTER
Award Amount
$586,150.00
Ceiling
$586,150.00
Awarded
December 16, 2025
Identifier
5U01AI172987-04
Award for developing microbiome therapeutics and dietary interventions to enhance intestinal barrier and reduce GI-ARS, funded by NIH/NIAID with $586,150 for FY 2026.
Description
This project aims to develop microbiome therapeutics and dietary interventions to promote intestinal barrier function and reduce GI-ARS after total body irradiation. The award is funded by the NIH/NIAID with a total amount of $586,150 for fiscal year 2026. The project involves developing live biotherapeutic products, genetically engineered probiotics, and evaluating prebiotic-enriched diets.